key: cord-0075942-z17x7d6t authors: Jiang, Michael; Lai, Timothy C.; Mitchell, David; Qu, Liang G. title: Extensive deep venous thrombosis in a young male with absent infrarenal inferior vena cava date: 2022-01-26 journal: J Vasc Surg Cases Innov Tech DOI: 10.1016/j.jvscit.2022.01.001 sha: 088d205447c3d5640d439823ffae86c20e06380e doc_id: 75942 cord_uid: z17x7d6t A previously well, independent 20-year-old man presented with a 4-day history of progressive left lower limb pain with associated phlegmasia cerulea dolens. Duplex venous ultrasound examination and computed tomography venogram revealed extensive deep vein thrombus from the left popliteal vein to abnormal venous vasculature proximally. Notably, no infrarenal inferior vena cava was detected, with distal venous return channeled through lumbar and visceral collateral channels into the azygous system. Treatment included systemic anticoagulation, catheter-directed thrombolysis, and prolonged therapeutic anticoagulation. In the absence of other risk factors, anatomical abnormalities should be considered in young, well patients presenting with lower limb venous thrombosis. Anomalies of the inferior vena cava (IVC) are rare conditions affecting less than 1% of the population, with agenesis of the infrarenal IVC being an uncommon subset. 1 The most common presentation is extensive lower limb (LL) deep venous thrombosis (DVT) in young, well patients without pre-existing risk factors. Up to 5% of DVT in this demographic is attributable to anatomic variations. 2 We present a case of IVC agenesis leading to extensive DVT in a well 20-year-old man who consented for this publication. We highlight the treatment pathways and the need to consider lifestyle factors for management. On examination, there was phlegmasia cerulea dolens of the left LL extending to the thigh. The skin was taut, especially over the lateral thigh, but compartments were soft with no pain on passive stretching. The right LL was unaffected. All LL pulses were palpable, and there were no neurological signs. Abdominal examination was unremarkable. After 6 months, the patient continued to be asymptomatic and had expressed wishes to continue playing contact sports. After discussion and counseling on the risks involved with contact sports, a shared decision was made with the patient and family to reduce the apixaban dose to 2.5 mg twice daily to balance bleeding and thromboembolism risks in the setting of permanent risk factors. 3 The patient was counseled to present to the emergency department immediately after any significant head impacts. The hematology department will continue to review and personalize the treatment regime to best balance the riskbenefit profile of management. Risk factors for DVT include genetic (eg, thrombophilia), congenital malformations, and acquired factors such as recent surgery, infections, and malignancy. [4] [5] [6] The main predisposing factor in this patient was an absent infrarenal IVCda rare venous malformation with prevalence estimated at 0.3%e0.5% of the population. 3, 7 However, it may be responsible for up to 5% of idiopathic DVTs in young patients without other identifiable risk factors. 7, 8 The infrarenal IVC develops from three paired veins at 4-8 weeks of gestation: the posterior cardinal, subcardinal, and supracardinal veins. [8] [9] [10] These form the IVC below the retrohepatic portion, along with the azygous and hemiazygous systems and the iliac veins. The absence of the infrarenal portion of the IVC is among the rarest of the anomalies described and is caused by failure of the posterior cardinal and supracardinal veins with preservation of the suprarenal segment. 11 In these patients, blood from LLs is shunted through multiple collateralsd including the azygous and hemiazygous systemsd emptying into the SVC. It has also been suggested that thrombosis of the IVC during development could lead to this condition. 12, 13 Anatomical drainage for patients with absent IVC predisposes to thrombosis, as distal venous shunting through collaterals results in venous stasis. 14, 15 Many cases subsequently present with DVT, with common precipitants being major physical exertion, anabolic steroids, and immobilization. 16, 17 Patients with this condition are generally male, under 40 years of age, and without other identifiable risk factors for thrombosis, presenting with DVT. 9, 18, 19 Thrombus burden can extend into the pelvis, leading to abdominal and lumbar pain; subsequent clot extension into the LLs may result in edema, venous insufficiency, and eventually ulceration. 15, 20 The mainstay of treatment is medical therapy. 10, 16 Oral anticoagulation has been used successfully with adjunctive lifestyle modifications including compression stockings, cessation of smoking, and avoiding long periods of immobilization. 21 These effective measures have been almost universally described for this patient population; however, duration of anticoagulation therapy remains controversial. 9, 15 Close clinical follow-up is required for these patients to monitor bleeding and thrombosis. In this case, this was of particular importance due to ongoing participation in contact sports; thus, an adapted anticoagulation plan was used after discussion with the patient. Few reports exist of surgical bypass for this condition, 19, 22, 23 with the first being reported by Dougherty in 1996. 24 In the acute setting, thrombolysis has been demonstrated to successfully remove clot burden, with multiple modalities described. [25] [26] [27] In this case, catheter-directed thrombolysis was used to acutely improve vessel patency in conjunction with systemic heparin infusion. Other endovascular interventions are also available including mechanical clot retrieval and ultrasound-driven techniques. 26,28-30 We demonstrate a successful case of catheter-directed thrombolysis in the treatment of extensive pelvic DVT in a patient with segmental infrarenal IVC agenesis. Along with consideration of acquired and genetic risk factors, vascular malformation should be a differential when investigating young patients with DVT. Acute treatment may include systemic and directed thrombolysis. Although long-term anticoagulation is still a topic for debate, there is a role for personalized treatment strategies to balance the risks of bleeding with thromboembolism. Agenesis of the inferior vena cava associated with lower extremities and pelvic venous thrombosis Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep-vein thrombosis Congenital absence of the inferior vena cava with bilateral iliofemoral acute deep venous thrombosis Venous thromboembolism Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis The Worcester Venous Thromboembolism study: a populationbased study of the clinical epidemiology of venous thromboembolism An extraordinary cause for deep venous thrombosis Absent infrarenal inferior vena cava Congenital absence of inferior vena cava: an under recognised cause of unprovoked venous thromboembolism Infrarenal inferior vena cava agenesis and recurrent deep vein thrombosis: a case report and literature review Developmental anomaly of the inferior vena cava Inferior vena cava anomalies and variations: imaging and rare clinical findings Absence of infrarenal inferior vena cava is not a congenital abnormality Pelvic congestion syndrome due to agenesis of the infrarenal inferior vena cava An unusual case of deep venous thrombosis in a young patient: congenital absence of the infrarenal portion of the inferior vena cava Inferior vena cava agenesis and deep vein thrombosis: 10 patients and review of the literature Combined anomaly of the right hepatic lobe agenesis and absence of the inferior vena cava: a case report Absent inferior vena cava resulting in exercise-induced epidural venous plexus congestion and lower extremity numbness: a case report and review of the literature Thrombectomy and surgical reconstruction for extensive iliocaval thrombosis in a patient with agenesis of the retrohepatic vena cava and atresia of the left renal vein Venous status ulcers due to congenital agenesis of the inferior vena cava in a 16-year-old male Deep venous thrombosis caused by congenital absence of inferior vena cava, combined with hyperhomocysteinemia Successful surgical management of pelvic congestion and lower extremity swelling owing to absence of infrarenal inferior vena cava Surgical management of deep venous insufficiency caused by congenital absence of the infrarenal inferior vena cava Congenitally absent inferior vena cava presenting in adulthood with venous stasis and ulceration: a surgically treated case Extravascular reconstruction of a congenitally absent inferior vena cava A rare cause of venous thrombosis: congenital absence (agenesis) of the inferior vena cava Efficacy of lower-extremity venous thrombolysis in the setting of congenital absence or atresia of the inferior vena cava Treatment of acute iliofemoral deep vein thrombosis Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum Interventional approaches to acute venous thromboembolism